Rachael Natrajan

19PUBLICATIONS
111CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersClimate change impacts and adaptation not elsewhere classifiedLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 22, 2026
The anion channel GPR89 is a tumor-specific dependency in breast cancer.

|Aug 18, 2025
Dysregulated SASS6 expression promotes increased ciliogenesis and cell invasion phenotypes.

Eleanor Hargreaves, Rebecca Collinson, Andrew D Jenks

|Mar 26, 2025
Proteogenomic discovery of RB1-defective phenocopy in cancer predicts disease outcome, response to treatment, and therapeutic targets.

Jacopo Iacovacci, Rachel Brough, Fatemeh Ahmadi Moughari

|Feb 12, 2025
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma.

James Stewart, Dragomir B Krastev, Rachel Brough

|Apr 10, 2024
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer.

John Alexander, Koen Schipper, Sarah Nash

|Mar 14, 2024
Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer.

Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull

Pageof 4

Frequent Collaborators

8 joint publications

Syed Haider

5 joint publications

Christopher J Lord

4 joint publications

Stephen Pettitt

3 joint publications

Ioanna Mavrommati